Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes

Cristina Rinaldi-Garaci, Enrico Garaci, Vera Del Gobbo, Cartesio Favalli, Teresa Jezzi, Allan L. Goldstein

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The effects of thymosin-α1 on the stimulation of specific release of prostaglandin E2 (PGE2) from splenic lymphocytes and thymocytes were studied. Experiments were also performed to study in parallel the absolute levels of thymosin-α1 in the blood and the induction of serum FTS activity and of azathioprine sensitivity of spleen cells from adult thymectomized (ATx) mice. A significant difference in the release of PGE2 between normal splenocytes and splenocytes from ATx mice was observed. Thymosin-α1 at certain concentrations was able to stimulate PGE2 release from lymphocytes of ATx mice while inhibiting release in lymphocytes of normal mice. Also, thymocytes were stimulated to release PGE2 after incubation with α1 in a manner similar to that seen in spleen cells of ATx mice. Approximately the same concentration of α1 was found to also correct the low azathioprine sensitivity of splenocytes from ATx mice. Determinations of FTS-like activity in the blood and the pharmacokinetics of α1 after administration of this synthetic molecule show a clear dissociation. A maximum peak of α1 activity was obtained after 1 hr, while maximal FTS-like activity was observed after 24 hr. The inhibition of the induction by α1 of FTS-like activity and of Thy 1.2 antigen by indomethacin suggests that the action of α1 requires prostaglandin biosynthesis.

Original languageEnglish
Pages (from-to)57-65
Number of pages9
JournalCellular Immunology
Volume80
Issue number1
DOIs
Publication statusPublished - 1983

Fingerprint

Thymosin
Prostaglandins
Lymphocytes
Dinoprostone
Azathioprine
Thymocytes
Spleen
Thy-1 Antigens
Indomethacin
Pharmacokinetics
Serum

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Rinaldi-Garaci, C., Garaci, E., Del Gobbo, V., Favalli, C., Jezzi, T., & Goldstein, A. L. (1983). Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes. Cellular Immunology, 80(1), 57-65. https://doi.org/10.1016/0008-8749(83)90093-X

Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes. / Rinaldi-Garaci, Cristina; Garaci, Enrico; Del Gobbo, Vera; Favalli, Cartesio; Jezzi, Teresa; Goldstein, Allan L.

In: Cellular Immunology, Vol. 80, No. 1, 1983, p. 57-65.

Research output: Contribution to journalArticle

Rinaldi-Garaci, C, Garaci, E, Del Gobbo, V, Favalli, C, Jezzi, T & Goldstein, AL 1983, 'Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes', Cellular Immunology, vol. 80, no. 1, pp. 57-65. https://doi.org/10.1016/0008-8749(83)90093-X
Rinaldi-Garaci, Cristina ; Garaci, Enrico ; Del Gobbo, Vera ; Favalli, Cartesio ; Jezzi, Teresa ; Goldstein, Allan L. / Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes. In: Cellular Immunology. 1983 ; Vol. 80, No. 1. pp. 57-65.
@article{8bda32ae02974c40a41f408649fc2bfd,
title = "Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes",
abstract = "The effects of thymosin-α1 on the stimulation of specific release of prostaglandin E2 (PGE2) from splenic lymphocytes and thymocytes were studied. Experiments were also performed to study in parallel the absolute levels of thymosin-α1 in the blood and the induction of serum FTS activity and of azathioprine sensitivity of spleen cells from adult thymectomized (ATx) mice. A significant difference in the release of PGE2 between normal splenocytes and splenocytes from ATx mice was observed. Thymosin-α1 at certain concentrations was able to stimulate PGE2 release from lymphocytes of ATx mice while inhibiting release in lymphocytes of normal mice. Also, thymocytes were stimulated to release PGE2 after incubation with α1 in a manner similar to that seen in spleen cells of ATx mice. Approximately the same concentration of α1 was found to also correct the low azathioprine sensitivity of splenocytes from ATx mice. Determinations of FTS-like activity in the blood and the pharmacokinetics of α1 after administration of this synthetic molecule show a clear dissociation. A maximum peak of α1 activity was obtained after 1 hr, while maximal FTS-like activity was observed after 24 hr. The inhibition of the induction by α1 of FTS-like activity and of Thy 1.2 antigen by indomethacin suggests that the action of α1 requires prostaglandin biosynthesis.",
author = "Cristina Rinaldi-Garaci and Enrico Garaci and {Del Gobbo}, Vera and Cartesio Favalli and Teresa Jezzi and Goldstein, {Allan L.}",
year = "1983",
doi = "10.1016/0008-8749(83)90093-X",
language = "English",
volume = "80",
pages = "57--65",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Modulation of endogenous prostaglandins by thymosin-α1 in lymphocytes

AU - Rinaldi-Garaci, Cristina

AU - Garaci, Enrico

AU - Del Gobbo, Vera

AU - Favalli, Cartesio

AU - Jezzi, Teresa

AU - Goldstein, Allan L.

PY - 1983

Y1 - 1983

N2 - The effects of thymosin-α1 on the stimulation of specific release of prostaglandin E2 (PGE2) from splenic lymphocytes and thymocytes were studied. Experiments were also performed to study in parallel the absolute levels of thymosin-α1 in the blood and the induction of serum FTS activity and of azathioprine sensitivity of spleen cells from adult thymectomized (ATx) mice. A significant difference in the release of PGE2 between normal splenocytes and splenocytes from ATx mice was observed. Thymosin-α1 at certain concentrations was able to stimulate PGE2 release from lymphocytes of ATx mice while inhibiting release in lymphocytes of normal mice. Also, thymocytes were stimulated to release PGE2 after incubation with α1 in a manner similar to that seen in spleen cells of ATx mice. Approximately the same concentration of α1 was found to also correct the low azathioprine sensitivity of splenocytes from ATx mice. Determinations of FTS-like activity in the blood and the pharmacokinetics of α1 after administration of this synthetic molecule show a clear dissociation. A maximum peak of α1 activity was obtained after 1 hr, while maximal FTS-like activity was observed after 24 hr. The inhibition of the induction by α1 of FTS-like activity and of Thy 1.2 antigen by indomethacin suggests that the action of α1 requires prostaglandin biosynthesis.

AB - The effects of thymosin-α1 on the stimulation of specific release of prostaglandin E2 (PGE2) from splenic lymphocytes and thymocytes were studied. Experiments were also performed to study in parallel the absolute levels of thymosin-α1 in the blood and the induction of serum FTS activity and of azathioprine sensitivity of spleen cells from adult thymectomized (ATx) mice. A significant difference in the release of PGE2 between normal splenocytes and splenocytes from ATx mice was observed. Thymosin-α1 at certain concentrations was able to stimulate PGE2 release from lymphocytes of ATx mice while inhibiting release in lymphocytes of normal mice. Also, thymocytes were stimulated to release PGE2 after incubation with α1 in a manner similar to that seen in spleen cells of ATx mice. Approximately the same concentration of α1 was found to also correct the low azathioprine sensitivity of splenocytes from ATx mice. Determinations of FTS-like activity in the blood and the pharmacokinetics of α1 after administration of this synthetic molecule show a clear dissociation. A maximum peak of α1 activity was obtained after 1 hr, while maximal FTS-like activity was observed after 24 hr. The inhibition of the induction by α1 of FTS-like activity and of Thy 1.2 antigen by indomethacin suggests that the action of α1 requires prostaglandin biosynthesis.

UR - http://www.scopus.com/inward/record.url?scp=0020561990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020561990&partnerID=8YFLogxK

U2 - 10.1016/0008-8749(83)90093-X

DO - 10.1016/0008-8749(83)90093-X

M3 - Article

C2 - 6575878

AN - SCOPUS:0020561990

VL - 80

SP - 57

EP - 65

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 1

ER -